Chemoinformaics analysis of Cephalotaxine,11-hydroxy
Molecular Weight | 331.368 | nRot | 1 |
Heavy Atom Molecular Weight | 310.2 | nRig | 24 |
Exact Molecular Weight | 331.142 | nRing | 5 |
Solubility: LogS | -2.792 | nHRing | 3 |
Solubility: LogP | 0.933 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
nHA | 6 | APOL | 49.1727 |
nHD | 2 | BPOL | 27.9853 |
QED | 0.808 |
Synth | 4.809 |
Natural Product Likeliness | 2.137 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.111 |
Pgp-sub | 0.839 |
HIA | 0.003 |
CACO-2 | -4.88 |
MDCK | 0.0000259 |
BBB | 0.985 |
PPB | 0.429946 |
VDSS | 3.728 |
FU | 0.533484 |
CYP1A2-inh | 0.423 |
CYP1A2-sub | 0.504 |
CYP2c19-inh | 0.148 |
CYP2c19-sub | 0.901 |
CYP2c9-inh | 0.109 |
CYP2c9-sub | 0.476 |
CYP2d6-inh | 0.853 |
CYP2d6-sub | 0.284 |
CYP3a4-inh | 0.779 |
CYP3a4-sub | 0.92 |
CL | 8.388 |
T12 | 0.32 |
hERG | 0.206 |
Ames | 0.212 |
ROA | 0.901 |
SkinSen | 0.241 |
Carcinogencity | 0.878 |
EI | 0.014 |
Respiratory | 0.93 |
NR-Aromatase | 0.078 |
Antiviral | Yes |
Prediction | 0.613667 |